Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Xinhe Biotechnology

Request full access

Innovative biotechnological solutions for sustainable DHA and EPA production, minimizing environmental impact and ensuring high purity

Xianning, ChinaFounded 2011Biotech & Life Sciences

About Xinhe Biotechnology

Hubei Xinhe Biological Technology Co. operates in the biotechnology sector, focusing on the sustainable production of DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid). These are essential omega-3 fatty acids typically found in fish oil, but Xinhe Bio has developed advanced methods to extract these nutrients from alternative sources, addressing issues like limited resources, instability in output, and contamination risks associated with traditional fish oil extraction. The company serves a diverse range of clients, including those in the pharmaceutical, nutraceutical, and food industries, who require high-purity omega-3 fatty acids for their products.

Xinhe Bio operates multiple specialized centers, including R&D, quality inspection, strain reserve, strain breeding, and analysis and testing centers. These facilities are equipped with over 50 types of advanced test equipment, such as atomic absorption and high-performance liquid chromatography, ensuring rigorous quality control and innovation in their production processes.

The company's business model revolves around leveraging its proprietary technology to produce and sell high-quality DHA and EPA. Revenue is generated through direct sales to manufacturers in the health and wellness sectors, as well as through partnerships and licensing agreements.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2011
Headquarters
Xianning, China
Employees
10
Open positions
None listed
Dealroom signal
22.7/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Dec 2021 $69M $275M CDH Investments · PICC Capital · Zhou Yahui · Shunxi Private Equity Fund Management ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Xinhe Biotechnology website traffic

Latest recorded traffic for Xinhe Biotechnology is 600 monthly website visits, up 7.1% over the last three months. Xinhe Biotechnology's team grew 0% over the past year.

Latest monthly visits600 3-month web change+7.1% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Xinhe Biotechnology in the Xianning ecosystem

Live from Dealroom

The Xinhe Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • CDH Investments
  • PICC Capital
  • Zhou Yahui
  • Shunxi Private Equity Fund Management
  • Jiayin Fund
Employees 10 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Xinhe Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Xinhe Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.